That's right IB. Epinephrine is not new, isn't subject to recovering R&D costs nor is it an uncommon or highly specialized drug. In fact the opposite is true
Pure selfish, uncaring greed is the only motivation. Mylan does present a compelling argument FOR government mandated price controls however with this bullchit.